Phibro Animal Health (PAHC) EBT Growth (1y) (2013 - 2026)
Phibro Animal Health (PAHC) EBT Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 48.64% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -393.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -24.84% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 92.01% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1,578.91% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 45.00% |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | 8.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.84% |
| Dec 31, 2025 | 652.89% |
| Sep 30, 2025 | 277.00% |
| Jun 30, 2025 | 187.26% |
| Mar 31, 2025 | 129.75% |
| Dec 31, 2024 | 35.71% |
| Sep 30, 2024 | 180.31% |
| Jun 30, 2024 | -227.46% |
| Mar 31, 2024 | -14.45% |
| Dec 31, 2023 | -70.56% |
| Sep 30, 2023 | -321.14% |
| Jun 30, 2023 | 73.34% |
| Mar 31, 2023 | -43.71% |
| Dec 31, 2022 | -48.54% |
| Sep 30, 2022 | -43.54% |
| Jun 30, 2022 | -23.29% |
| Mar 31, 2022 | 50.90% |
| Dec 31, 2021 | 46.59% |
| Sep 30, 2021 | -41.88% |
| Jun 30, 2021 | 138.14% |